These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31053499)

  • 1. Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.
    Wang Z; Wang A; Gong Z; Biviano I; Liu H; Hu J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):410-416. PubMed ID: 31053499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood coagulation and fibrinolysis in relation to endotoxemia in liver cirrhosis and hepatocellular carcinoma].
    Kato S; Kawasaki H
    Nihon Shokakibyo Gakkai Zasshi; 1995 Aug; 92(8):1143-8. PubMed ID: 7563921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.
    Ruan P; Gong ZJ; Zhang QR
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.
    Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Triantos C; Vagianos CE; Spiliopoulou I; Kaltezioti V; Charonis A; Nikolopoulou VN; Scopa CD; Thomopoulos KC
    Eur J Clin Invest; 2012 Apr; 42(4):439-46. PubMed ID: 22023490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.
    Ataseven H; Bahcecioglu IH; Kuzu N; Yalniz M; Celebi S; Erensoy A; Ustundag B
    Mediators Inflamm; 2006; 2006(4):78380. PubMed ID: 17047295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis.
    Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Zisimopoulos D; Maroulis I; Kontogeorgou E; Georgiou CD; Scopa CD; Thomopoulos KC
    Ann Hepatol; 2013; 12(2):301-7. PubMed ID: 23396742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure.
    Wang LK; Wang LW; Li X; Han XQ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):180-8. PubMed ID: 23558073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
    Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
    BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of TNF-alpha and endotoxemia in patients with chronic liver diseases].
    Xie J; Lin M; Liu A; Fan X
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):164-6. PubMed ID: 11938780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
    Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation.
    Lee FY; Lu RH; Tsai YT; Lin HC; Hou MC; Li CP; Liao TM; Lin LF; Wang SS; Lee SD
    Scand J Gastroenterol; 1996 May; 31(5):500-5. PubMed ID: 8734349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha increases intestinal permeability in mice with fulminant hepatic failure.
    Li GZ; Wang ZH; Cui W; Fu JL; Wang YR; Liu P
    World J Gastroenterol; 2012 Sep; 18(36):5042-50. PubMed ID: 23049212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
    Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
    Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.
    Chen TA; Tsao YC; Chen A; Lo GH; Lin CK; Yu HC; Cheng LC; Hsu PI; Tsai WL
    Scand J Gastroenterol; 2009; 44(5):619-25. PubMed ID: 19191184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.
    Choi Y; Jeon WK; Hwang SJ; Kim BI; Sohn CI; Park DI; Cho YK; Kim HJ; Park JH
    Hepatogastroenterology; 2011; 58(109):1244-7. PubMed ID: 21937387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
    Moussa YI; Plevris JN; Hayes PC
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.